These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


266 related items for PubMed ID: 17068401

  • 21. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL.
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract] [Full Text] [Related]

  • 25. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U.
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [Abstract] [Full Text] [Related]

  • 26. What happened to WHI: menopausal hormonal therapy in 2012.
    Hansen KA, Eyster KM.
    Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
    [Abstract] [Full Text] [Related]

  • 27. Update on hormone replacement therapy.
    Gambrell RD.
    Am Fam Physician; 1992 Nov; 46(5 Suppl):87S-96S. PubMed ID: 1442475
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.
    JAMA; 2002 Aug 21; 288(7):872-81. PubMed ID: 12186605
    [Abstract] [Full Text] [Related]

  • 30. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 Aug 21; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 31. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP.
    Curr Womens Health Rep; 2003 Jun 21; 3(3):181-6. PubMed ID: 12734027
    [Abstract] [Full Text] [Related]

  • 32. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE.
    N Engl J Med; 1995 Jun 15; 332(24):1589-93. PubMed ID: 7753136
    [Abstract] [Full Text] [Related]

  • 33. Systemic lupus erythematosus and hormone replacement therapy.
    Gompel A, Piette JC.
    Menopause Int; 2007 Jun 15; 13(2):65-70. PubMed ID: 17540136
    [Abstract] [Full Text] [Related]

  • 34. Controversies in HRT.
    Teede HJ.
    Aust Fam Physician; 2002 May 15; 31(5):413-8. PubMed ID: 12043543
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Preventing of postmenopausal osteoporosis by hormone replacement therapy? Is the risk acceptable?].
    Wirthner D, Cornuz J, Lamy O.
    Praxis (Bern 1994); 2004 Feb 25; 93(9):315-20. PubMed ID: 15060972
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.